More than 32 million adults in the United States currently have diabetes, 90% of whom have type 2 diabetes (T2D) which can lead to both microvascular and macrovascular complications, and greatly compromise health-related quality of life (HRQoL) and confer significant …
Neurodiversity and mental health often intersect. In differentiating psychiatric conditions (e.g., depression, anxiety) from cognitive conditions (e.g., autism spectrum disorder), health care professionals (HCPs) must facilitate accurate diagnosis, appropriate selection of treatments, and individualized care. As accurate assessment is key …
Individuals who are neurodiverse can bring unique skills to the workforce; however, discrimination, implicit bias, and stigma exist. To ease stress for these individuals, health care professionals (HCPs) and employers can foster inclusivity by realizing that each person is different …
Palliative care is an underutilized health care service, especially in underserved communities, often because patients, their families, and health care professionals (HCPs) have misperceptions about it and are unclear about the services it provides. Palliative care, which is available at …
Treatment for primary biliary cholangitis (PBC), a “common rare” chronic autoimmune disease of the intrahepatic bile ducts, is frequently hampered by missed or delayed diagnosis, as symptoms of PBC are often attributed to other conditions. This suboptimal recognition enables unchecked …
Acromegaly presents a diagnostic and management challenge due to its gradual onset, diverse symptoms, and complex treatment landscape. Delays in diagnosis and suboptimal care lead to prolonged morbidity and increased mortality. However, emerging therapies, including novel oral options, offer new …
Early detection and treatment of human immunodeficiency virus (HIV) and hepatitis B and C (HBV, HCV) are paramount to mitigating the damage associated with these diseases, thus allowing patients to live longer, healthier lives; but many patients do not receive …
Acromegaly presents a diagnostic and management challenge due to its gradual onset, diverse symptoms, and complex treatment landscape. Delays in diagnosis and suboptimal care lead to prolonged morbidity and increased mortality. However, emerging therapies, including novel oral options, offer new …
Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy with early childhood manifestations that results in developmental delays, behavioral issues, and cognitive dysfunction. Alongside treatment-resistant seizures, patients with LGS experience a wide range of non-seizure symptoms that severely impact quality of …